Paul Hudson: A Mindset for Miracles

Paul Hudson: A Mindset for Miracles

As board chair-elect of the Pharmaceutical Research and Manufacturers of America (PhRMA), Paul Hudson is set to succeed Pfizer CEO Albert Bourla, PhD, in the US trade group’s top seat in 2026. Touching on the annual changeover during a recent wide-ranging sit-down with Pharmaceutical Executive at Sanofi’s Washington, DC, office, the CEO of the French…

Read More
Pharmaceutical Executive Daily: September 17, 2025

Pharmaceutical Executive Daily: September 17, 2025

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, we cover Lilly’s orforglipron as a prime candidate for FDA fast-track approval, Merck and Daiichi Sankyo’s breakthrough therapy designation for R-DXd in ovarian cancer, and Novo Nordisk’s EU approval of Rybelsus…

Read More